ULBI•October 28, 2026 at 10:00 AM UTCEnergy

Ademi LLP Investigates $16/Share EnerSys Buyout of Ultralife; Offer Near DCF Value

Read source article

What happened

Ademi LLP announced an investigation into whether EnerSys's proposed acquisition of Ultralife at $16.00 per share (enterprise value ~$320 million) fairly compensates shareholders. This follows our prior analysis, which valued ULBI at approximately $16.18 per share using a DCF model, suggesting the deal price is close to intrinsic value. The investigation focuses on the deal process, potential insider benefits, and any restrictions on competing offers. While the buyout price represents a significant premium to the recent trading price of around $5.65, it remains slightly below our DCF estimate, raising questions about whether shareholders are leaving value on the table. The outcome of the investigation and any competing bids will determine if the transaction proceeds as planned or if shareholders receive a higher price.

Implication

If the deal completes at $16, investors will realize a gain of roughly 183% from the prior price, but they would forgo any future upside if Ultralife's operational improvements eventually justified a higher valuation. The law firm's scrutiny could lead to a higher bid or additional disclosures that reveal more value. However, if the investigation finds no wrongdoing and the deal is approved, the stock will likely trade near the $16 offer price with limited upside unless a superior offer emerges. Investors should weigh the certainty of $16 against the possibility of a higher price or the risk of the deal falling through, which could send shares back to their pre-announcement levels.

Thesis delta

The acquisition at $16.00 per share aligns closely with our DCF value of $16.18, confirming that the market was undervaluing ULBI due to near-term execution issues. The thesis shifts from 'potential buy' to 'watch for deal completion', as the asymmetric risk-reward from the previous price is largely captured by the offer. However, the shareholder investigation introduces uncertainty about whether the deal will close at this price and whether there is untapped value that could justify a higher bid.

Confidence

Moderate